These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 1749068)
1. Hemodynamic efficacy of E-1020 in comparison with dopamine on acute mitral regurgitation in anesthetized dogs. Tanio H; Kumada T; Hayashi M; Himura Y; Nakamura Y; Kawai C Jpn Circ J; 1991 Nov; 55(11):1068-76. PubMed ID: 1749068 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 2nd communication: studies in dogs. Ohhara H; Ogawa T; Takeda M; Katoh H; Daiku Y; Igarashi T Arzneimittelforschung; 1989 Jan; 39(1):38-45. PubMed ID: 2719742 [TBL] [Abstract][Full Text] [Related]
3. Acute hemodynamic effects of MDL19205 on conscious dogs with mitral regurgitation. Susawa T; Kihara Y; Miyazaki S; Nakamura Y; Sasayama S; Kawai C Cardiovasc Drugs Ther; 1988 Sep; 2(3):305-11. PubMed ID: 3154914 [TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 1st communication: studies on isolated guinea pig cardiac muscles. Ogawa T; Ohhara H; Tsunoda H; Kuroki J; Shoji T Arzneimittelforschung; 1989 Jan; 39(1):33-7. PubMed ID: 2566308 [TBL] [Abstract][Full Text] [Related]
5. Effects of the new cardiotonic phosphodiesterase inhibitor 1,2-dihydro-5- imidazo[1,2-a]pyridin-6-yl-6-methyl-2-oxo-3-pyridine-carbonitrile hydrochloride monohydrate on aortic input impedance. Kubota T; Itaya R; Todaka K; Sugimachi M; Sunagawa K; Takeshita A Arzneimittelforschung; 1991 Dec; 41(12):1211-5. PubMed ID: 1815518 [TBL] [Abstract][Full Text] [Related]
6. [Effects of the new cardiotonic agent loprinone hydrochloride (E-1020) on left ventricular diameter in normal and experimental heart failure dogs and its action potential characteristics in isolated guinea pig cardiac muscles and sinus nodes]. Ohhara H; Sawada K; Ogawa T; Takeda M; Igarashi T Nihon Yakurigaku Zasshi; 1992 Jun; 99(6):421-33. PubMed ID: 1398339 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects of AR-L115 BS in conscious dogs with and without chronic congestive heart failure. Pouleur H; Rousseau MF; van Mechelen H; Roncoroni L; Ries A; Charlier AA J Cardiovasc Pharmacol; 1982; 4(3):409-18. PubMed ID: 6177937 [TBL] [Abstract][Full Text] [Related]
8. Comparative effects of inotropic agents on coronary and systemic hemodynamics of conscious dogs: actions of milrinone, dopamine, ouabain and MCI-154. Al-Wathiqui MH; Shimshak TM; Brooks HL; Preuss KC; Wynsen JC; Gross GJ; Warltier DC Pharmacology; 1988; 36(4):217-27. PubMed ID: 3380877 [TBL] [Abstract][Full Text] [Related]
9. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs. Harkin CP; Pagel PS; Tessmer JP; Warltier DC J Cardiovasc Pharmacol; 1995 Aug; 26(2):179-88. PubMed ID: 7475041 [TBL] [Abstract][Full Text] [Related]
10. Imidazo[1,2-a]pyridines. I. Synthesis and inotropic activity of new 5-imidazo[1,2-a]pyridinyl-2(1H)-pyridinone derivatives. Yamanaka M; Miyake K; Suda S; Ohhara H; Ogawa T Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1556-67. PubMed ID: 1934178 [TBL] [Abstract][Full Text] [Related]
11. Hemodynamic and myocardial energetic effects of CK-3197, a selective positive inotropic agent. Greenberg S; Touhey B J Cardiovasc Pharmacol; 1991 Jan; 17(1):145-53. PubMed ID: 1708048 [TBL] [Abstract][Full Text] [Related]
12. Effects of a new cardiotonic phosphodiesterase III inhibitor, olprinone, on cardiohemodynamics and plasma hormones in conscious pigs with heart failure. Adachi H; Tanaka H J Cardiovasc Pharmacol; 1997 Jun; 29(6):763-71. PubMed ID: 9234657 [TBL] [Abstract][Full Text] [Related]
13. Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs. Pagel PS; Harkin CP; Hettrick DA; Warltier DC Anesthesiology; 1994 Oct; 81(4):974-87. PubMed ID: 7943849 [TBL] [Abstract][Full Text] [Related]
14. Effects of a new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-[imidazo (1,2-a) pyridin-6-yl]-3-pyridine carbonitrile hydrochloride monohydrate (E-1020) on contractile force and cyclic AMP metabolism in canine ventricular muscle. Satoh H; Endoh M Jpn J Pharmacol; 1990 Feb; 52(2):215-24. PubMed ID: 2156096 [TBL] [Abstract][Full Text] [Related]
15. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness. Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774 [TBL] [Abstract][Full Text] [Related]
16. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside. Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022 [TBL] [Abstract][Full Text] [Related]
17. Levosimendan potentiates the inotropic actions of dopamine in conscious dogs. McGough MF; Pagel PS; Lowe D; Hettrick DA; Warltier DC J Cardiovasc Pharmacol; 1996 Jul; 28(1):36-47. PubMed ID: 8797134 [TBL] [Abstract][Full Text] [Related]
18. The inotropic and hemodynamic effects of intravenous milrinone when reflex adrenergic stimulation is suppressed by beta-adrenergic blockade. Travill CM; Pugh S; Noble MI Clin Ther; 1994; 16(5):783-92. PubMed ID: 7859237 [TBL] [Abstract][Full Text] [Related]
19. Effects of intracoronary infusion of an inotropic agent, E-1020 (loprinone hydrochloride), on cardiac function: evaluation of left ventricular contractile performance using the end-systolic pressure-volume relationship. Murakami R; Sano K; Murakami Y; Shimada T; Morioka S Int J Cardiol; 1995 Aug; 51(1):57-63. PubMed ID: 8522398 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties. Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]